ABR-215050

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.

2013

2013

Abstract B17: Immunomodulation by tasquinimod: Combination with immunotherapy results in enhanced CD8 T cell responses and improved antitumor effects.

A. SundstedtAnders H. Olsson T. Leanderson
2013
Corpus ID: 72403233

Purpose: The novel anti-tumor agent tasquinimod (ABR-215050) is being developed for treatment of metastatic castration-resistant…